These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 12690657

  • 1. [Guillain-Barre syndrome and its frontiers].
    Azulay JP, Verschueren A, Attarian S, Pouget J.
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S21-6. PubMed ID: 12690657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Guillain-Barré syndrome.
    Arcila-Londono X, Lewis RA.
    Semin Neurol; 2012 Jul; 32(3):179-86. PubMed ID: 23117942
    [Abstract] [Full Text] [Related]

  • 7. [Guillain-Barré syndrome in childhood].
    Kollár K, Liptai Z, Rosdy B, Móser J.
    Ideggyogy Sz; 2009 Nov 30; 62(11-12):399-404. PubMed ID: 20025130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [History of Guillain-Barré Syndrome].
    Kusunoki S.
    Brain Nerve; 2015 Nov 30; 67(11):1295-303. PubMed ID: 26560944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
    Puma A, Benoit J, Sacconi S, Uncini A.
    BMC Neurol; 2018 Jul 21; 18(1):101. PubMed ID: 30031375
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV.
    Ann Neurol; 1998 Nov 21; 44(5):780-8. PubMed ID: 9818934
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
    Nomura K.
    Rinsho Shinkeigaku; 1996 Dec 21; 36(12):1367-9. PubMed ID: 9128414
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 20. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.
    Rajabally YA, Hassan-Smith G, Notturno F, Eames PJ, Hayton T, Capasso M, Uncini A.
    J Neurol Sci; 2011 Apr 15; 303(1-2):35-8. PubMed ID: 21316711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.